Glaucoma and Systemic Disease

被引:14
作者
Hsu, Eugene [1 ]
Desai, Manishi [1 ]
机构
[1] Boston Univ, Sch Med, Dept Ophthalmol, 85 East Concord St, 8th Floor, Boston, MA 02118 USA
来源
LIFE-BASEL | 2023年 / 13卷 / 04期
关键词
ophthalmology; glaucoma; open-angle glaucoma; closed-angle glaucoma; systemic disease; acute angle closure glaucoma; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; BLOOD-PRESSURE; OCULAR HYPERTENSION; RISK-FACTORS; ASSOCIATION; PSEUDOEXFOLIATION; INTRAVITREAL; IMPLANT; UVEITIS;
D O I
10.3390/life13041018
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glaucoma is the leading cause of irreversible blindness in the world. Due to its potential to cause permanent vision loss, it is important to understand how systemic conditions and their respective treatments can be associated with or increase the risk for developing glaucoma. In this review, we examined the literature for up-to-date discussions and provided commentary on glaucoma, its pathophysiology, and associated risk factors. We discuss systemic diseases and the impact, risk, and mechanism for developing glaucoma, including pharmacologically induced glaucoma; inflammatory and auto-immune conditions; infectious, dermatologic, cardiovascular, pulmonary, renal, urologic, neurologic, psychiatric and systemic malignancies: intraocular tumors; as well as pediatric, and genetic conditions. The goal of our discussion of systemic conditions including their commonality, mechanisms, treatments, and associations with developing glaucoma is to emphasize the importance of ocular examinations and follow-up with the multidisciplinary teams involved in the care of each patient to prevent unnecessary vision-loss.
引用
收藏
页数:19
相关论文
共 74 条
[21]   Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids [J].
Garbe, E ;
LeLorier, J ;
Boivin, JF ;
Suissa, S .
LANCET, 1997, 350 (9083) :979-982
[22]   Nocturnal hypotension: Role in glaucoma progression [J].
Graham, SL ;
Drance, SM .
SURVEY OF OPHTHALMOLOGY, 1999, 43 :S10-S16
[23]   Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging [J].
Gupta, N. ;
Greenberg, G. ;
de Tilly, L. Noeel ;
Gray, B. ;
Polemidiotis, M. ;
Yuecel, Y. H. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (01) :56-60
[24]   Retinal tau pathology in human glaucomas [J].
Gupta, Neeru ;
Fong, Jessica ;
Ang, Lee C. ;
Yuecel, Yeni H. .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2008, 43 (01) :53-60
[25]  
Havens SJ, 2016, DEV OPHTHALMOL, V55, P196, DOI 10.1159/000431196
[26]   Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion [J].
Hayashi, K ;
Hayashi, H .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (06) :972-982
[27]   Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial [J].
Heijl, A ;
Leske, MC ;
Bengtsson, B ;
Hyman, L ;
Bengtsson, B ;
Hussein, M .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1268-1279
[28]   Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function [J].
Hoffmanova, Iva ;
Sanchez, Daniel .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (04) :796-799
[29]   Migraine and increased risk of developing open angle glaucoma: a population-based cohort study [J].
Huang, Jehn-Yu ;
Su, Chien-Chia ;
Wang, Tsing-Hong ;
Tsai, I-Ju .
BMC OPHTHALMOLOGY, 2019, 19 (1)
[30]   Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies [J].
Ishii, Mai ;
Horita, Nobuyuki ;
Takeuchi, Masaki ;
Matsumoto, Hiromi ;
Ebina-Shibuya, Risa ;
Hara, Yu ;
Kobayashi, Nobuaki ;
Mizuki, Nobuhisa ;
Kaneko, Takeshi .
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2021, 13 (03) :435-449